Hims Labs is best for broad, app-native preventive labs processed through Quest, with telehealth on the same platform. Hone Health is best for men's hormone-focused testing inside a physician-led care program. AMORTAL is neither lab nor clinician: it adds independent cross-provider memory, keeps medication-class questions clinician-ready, and tracks whether a protocol worked — it prepares and tracks, never directs treatment.
Hims Labs and Hone Health both pair lab testing with telehealth — but they’re built on different bets. Hims leans into a broad, app-native preventive entry point: a wide panel processed through Quest Diagnostics, booked and read inside the same app you’d use for telehealth. Hone leans into men’s hormone-focused care: a narrower panel built around a physician-led program, with consults, treatment plans and follow-up retesting.
Both answer “what do my numbers look like, and who can treat them?” in their own way. Neither is built to answer the harder, independent question that comes next: “so what should I actually change, what belongs with a prescribing clinician, and did the plan work?” That’s the gap this page is about — and where AMORTAL fits, on top of whichever one you pick, as an independent layer that prepares and tracks but never directs treatment. It’s educational, not medical advice.
vs
+
Use Hims Labs or Hone Health for the testing and the care. Use AMORTAL to keep an independent memory across providers, keep medication-class questions clinician-ready, and track whether the plan worked — it never directs treatment.
The short version: who each is for
Two of these test and treat in different shapes; the third decides what to do with whichever you have. Here’s the honest split.
Which one fits which job
Hims LabsBest for app-native preventive labsA broad preventive panel processed through Quest Diagnostics and booked through the app, with telehealth on the same platform. Strongest when you want a wide, app-native baseline and care in one place.
Hone HealthBest for hormone-care telehealthA men's hormone-focused testing and care program — physician consults, treatment plans and follow-up retesting, with labs drawn at Quest locations. Strongest when hormone-related care, not just a number, is the point.
AMORTALBest for deciding what to do nextNot a lab and not a clinician. A longitudinal decision layer that reads whatever results you already have — from either provider — and returns independent memory, one ranked next action, a clinician-ready question, and an outcome loop. Including when to do nothing, and it never directs treatment.
This isn't an "A beats B." Hims and Hone answer what are my numbers, and who treats them in different shapes; AMORTAL answers what should they change — independently, and without directing treatment. The strongest setup is one provider plus AMORTAL.
Hims Labs vs Hone Health vs AMORTAL, at a glance
Tap between the three to see what each is actually responsible for.
What each one owns
Same goal — better decisions from your labs — split into a broad preventive entry, a hormone-focused care program, and one independent decision layer.
Hims Labs — the app-native baseline
A broad preventive lab entry point: Hims advertises 130+ biomarker tests across 10 health areas, processed by Quest Diagnostics, with appointments bookable at around 2,000 Quest locations through the app — and telehealth on the same platform.
You want a wide, app-native preventive baseline with care in one place. Verify the current panel, price and what's included before buying.
Hone Health — the hormone-focused program
A men's hormone-focused testing and care program: Hone advertises 50+ biomarker testing with HSA/FSA eligibility and no insurance required, labs at Quest locations, telehealth physician consults, treatment plans and retesting/follow-ups.
You want hormone-related testing inside a physician-led care program, not just a number. Any medication-class decision belongs with the prescribing clinician. Verify current claims and pricing before buying.
AMORTAL — the decision layer
Not a lab or a clinician. It takes either provider's results, normalises them into an independent memory, and produces one ranked next action, a clinician-ready question, and an outcome loop — with restraint built in, and without directing treatment.
You already have results and the real question is "what now?" — what to change, what to keep clinician-side, what to watch, and whether the plan actually worked.
AMORTAL has no direct integration with either — you bring the data in by upload or manual entry.
The comparison, row by row
| Dimension | Hims Labs | Hone Health | AMORTAL |
|---|---|---|---|
| Best use case | App-native preventive baseline | Men’s hormone-focused care program | Deciding what the data should change |
| Collection method | Draw at Quest locations via the app (advertised) | Draw at Quest locations (advertised) | No draws — works from results you have |
| Lab partner / processing | Processed by Quest Diagnostics (advertised) | Quest locations (as advertised) | Lab-agnostic; vendor-neutral |
| Biomarker breadth | Broad panel (advertises 130+ across 10 areas) | Hormone-focused (advertises 50+) | Doesn’t test; reads whatever you bring |
| Wearable integration | Not the core product | Not the core product | Connects labs to Oura / Whoop / Apple Watch |
| Upload existing labs | Its own panel | Its own panel | Yes — bring either provider’s results in |
| Clinician review | Telehealth on the same platform (advertised) | Physician consults + treatment plans (advertised) | Clinician-compatible questions; not a clinician |
| Action plan depth | App-based results + telehealth (advertised) | Physician-led plans + follow-ups (advertised) | One ranked next best action, plus restraint |
| Retesting cadence | Per-panel / membership cadence | Retesting + follow-ups (advertised) | Tells you when not to retest yet |
| Result trend tracking | In-app history | Program follow-up trends | Longitudinal memory across providers and time |
| Abnormal-result handling | Telehealth follow-up (as advertised) | Physician care routing (as advertised) | Safety-gated; routes urgent flags to a clinician |
| Cost model | Membership / per-panel (verify current) | HSA/FSA eligible, no insurance required (verify) | Decision layer — founding membership |
| Where AMORTAL fits | App-native panel in | Hormone-care data in | → ranked decision, watchlist, outcome loop out |
Provider rows describe what each company publicly advertises as of June 2026 — pricing, panel size, partner locations and included care change often, so confirm current details on each provider's own pages before buying. Sources are at the foot of this page.
Which one fits what you actually want
| What you want | Reach for |
|---|---|
| A broad, app-native preventive baseline with care in one place | Hims Labs |
| Telehealth and labs bought through one app | Hims Labs |
| Men’s hormone-focused testing inside a physician-led program | Hone Health |
| A care program with consults, treatment plans and follow-ups | Hone Health |
| I already have results — tell me what to do next | AMORTAL |
| An independent record that spans both providers | AMORTAL |
| To keep a medication-class question clinician-ready, not self-directed | AMORTAL |
| To track whether a hormone or preventive protocol actually worked | AMORTAL |
| To know whether I should retest yet | AMORTAL |
| The bigger picture, not a single app’s dashboard | AMORTAL |
Where AMORTAL fits — whichever you pick
The model is the same regardless of which platform you choose: let the provider do the testing and the care, then run the result through an independent decision process instead of a dashboard.
- Bring the result in. Upload your Hims Labs or Hone Health report, or enter the key markers — there's no direct integration, so you carry the data over.
- Normalise into memory. AMORTAL files each biomarker into a longitudinal record, not a one-off screen.
- Connect the context. Results are linked to your goals, symptoms, wearables, medications and constraints.
- Activate the standards. The guidelines and decision rules that actually apply to your situation switch on.
- Produce a Decision Contract. One change at a time, with the expected signal and the window written down in advance.
- Rank one Next Best Action. Not ten. The single highest-value move — which may be "do nothing yet," and anything medication-class stays a clinician-ready question, never a directive.
- Set the watchlist. Markers worth re-checking get an expected direction and a recheck window.
- Close the loop. When the next panel or outcome signal arrives, AMORTAL checks whether the action worked — and keeps or discards it.
A decision loop, end to end
Here’s the same flow on a single example — illustrative numbers only, not a target or a reference range, and not a treatment recommendation.
From a result to a tracked outcome
Your Hone or Hims panel returns a total testosterone in a range your clinician flags as worth attention (illustrative only). On an app screen, that's a number and a prompt to book a consult.
AMORTAL files it next to your prior hormone and metabolic markers, your goals and symptoms — read as a trajectory, not a single dot.
One question, not five. The signal you'd expect to move and the window to see it are written down before anything changes — but the change itself stays clinician-side.
Framed as a clinician-ready question — "given this trend, what should we confirm or rule out first?" — never a treatment, dosing or TRT directive, which AMORTAL has no authority to give.
The marker goes on watch with an expected direction and a recheck window — so any retest is informative, not on a guess or a renewal date.
At the next draw — after whatever your clinician decides — AMORTAL checks: did it move as expected? If yes, the plan earns its place; if not, that's logged too. No story told over noise.
AMORTAL doesn't diagnose, doesn't prescribe, and isn't a substitute for your clinician — anything urgent, and any medication-class decision, goes to a professional, now.
Hims Labs or Hone Health — which fits you?
If you’re choosing between the two, this narrows it. Whichever you land on, AMORTAL sits on top of it — independently, and without directing treatment.
Hims, Hone, or it doesn't matter?
What are you mainly testing for?
Will a result here likely lead to a medication-class decision?
Hims fits broad app-native preventive labs — verify the current panel and price, get the draw at Quest, then bring the results into AMORTAL for an independent decision trail.
Hone fits hormone-focused physician care — AMORTAL keeps the medication-class questions clinician-ready and tracks outcomes; it never directs treatment.
If a medication-class decision is likely, that belongs with a prescribing clinician (Hone provides one); AMORTAL prepares the questions and the trend — it never directs hormone treatment or dosing.
Where each is strongest — and where it isn’t
In fairness to all three:
- Hims is strongest when you want a broad, app-native preventive baseline with telehealth in one place — and less ideal if your bottleneck is deciding on data you already have, independently of the app that sold it.
- Hone is strongest when you want hormone-related testing inside a physician-led program with consults and follow-ups — and less ideal if you’d rather keep your longitudinal record separate from a single treatment-linked platform.
- Verify before you buy. Panel size, prices, eligibility and included care change for both — confirm the current details on each provider’s own pages.
- Breadth is a beginning, not an answer. Some results need a clinician, and any medication-class decision stays clinician-side; AMORTAL should never be read as a diagnosis or a treatment directive, whichever provider produced the number.
Bring your results into a decision, not a dashboard
AMORTAL doesn’t need to be where you buy your labs or your care. The stronger model is to let a provider like Hims or Hone do the testing and the telehealth, then use AMORTAL as the independent, longitudinal decision system around those results. Upload the report, or enter the markers that matter. AMORTAL turns the result into memory, evaluates what’s still missing, ranks the next best action, frames anything medication-class as a clinician-ready question, sets a watchlist for the signals to expect, and later checks whether the action actually worked.
Already have results from Hims Labs or Hone Health? Bring them into AMORTAL and ask the only question that matters: “What should I do next?”
Sources
Provider claims describe what each company publicly advertised when this page was last fact-checked (26 June 2026). Panel size, pricing, eligibility and included care are volatile — verify on the official pages before purchase.
Hims Labs — lab claims, pricing and what's included with the app-native panel.
Hims Labs FAQ — panel detail: biomarker tests, health areas and Quest processing.
Hone Health — program claims: biomarker testing, HSA/FSA eligibility, consults and treatment plans.
Hone Health — how it works: lab draw, physician consults, plans and retesting/follow-ups.
Educational only — this is not medical advice or a diagnosis. Talk to a licensed clinician about your own numbers, targets, and any treatment decisions.
Frequently asked
Hims Labs vs Hone Health — which should I choose?
It depends on what you want. Hims Labs is strongest as a broad, app-native preventive baseline — a wide panel processed by Quest and booked through the app, with telehealth alongside it. Hone Health is strongest as a men's hormone-focused program — physician consults, treatment plans and follow-up retesting. Both publish their own claims and pricing, which change often, so verify before buying. Whichever you pick, AMORTAL works on top of the results as an independent layer and never directs treatment.
Can AMORTAL work with results from either Hims Labs or Hone Health?
Yes. AMORTAL is lab-agnostic and works from results you already have — you bring them in by uploading the report or entering key markers, since there is no direct integration with either. It normalises the biomarkers into an independent longitudinal memory, connects them to your goals, wearables and history, and returns one ranked next action rather than another dashboard. The provider you chose stays your data source and your care; AMORTAL is the decision layer.
Does AMORTAL replace Hims Labs or Hone Health?
No. They do a different job. Hims and Hone produce lab data and provide the telehealth or physician care around it; AMORTAL decides what that data should change, what to watch, when to retest, and which questions belong with a clinician. Most people keep their provider for the testing and care and use AMORTAL to turn each result into an auditable decision and an outcome loop. AMORTAL never prescribes or directs treatment.
Is a bigger panel always better, and when should I retest?
Not automatically. Hims advertises a broad preventive panel and Hone a narrower hormone-focused one — breadth helps a baseline, but more markers also mean more borderline results that tempt over-reaction. AMORTAL weighs whether a marker actually changes a realistic decision and sets an expected window per marker, telling you when a retest would be informative versus premature. Retesting too early is a common way to misread normal variation as a result.
Hone Health offers hormone treatment — does AMORTAL recommend TRT or dosing?
No, and that boundary is deliberate. Any medication-class decision — including hormone therapy or dosing — belongs with the prescribing clinician, which is what a program like Hone provides. AMORTAL prepares the clinician-ready questions and the trend behind them, then tracks the outcome over time. It never directs, recommends or adjusts treatment, and anything urgent goes to a professional now.
Both Hims and Hone are treatment-linked — why add an independent layer?
Because a platform that also sells the treatment has a different vantage point than a neutral record of your data. AMORTAL adds independent, cross-provider memory: it keeps the longitudinal context in one place, frames medication-class questions so they stay clinician-compatible, and tracks whether a protocol actually worked — regardless of which provider produced the number. It prepares and tracks; it does not direct treatment.